scispace - formally typeset
Journal ArticleDOI

Next-generation sequencing applied to molecular diagnostics

Reads0
Chats0
TLDR
The contribution of next-generation sequencing technologies to diagnosis and cancer prognostication and prediction and a great degree of bioinformatic expertise is focused on.
Abstract
Next-generation sequencing technologies have begun to revolutionize the field of cancer genetics through rapid and accurate assessment of a patient's DNA makeup with minimal cost. These technologies have already led to the realization of the inter- and intra-tumor genetic heterogeneity and the identification of novel mutations and chimeric genes, however, several challenges lie ahead. Given the low number of recurrent somatic genetic aberrations in common types of cancer, the identification of 'driver' genetic aberrations has proven challenging. Furthermore, implementation of next-generation sequencing and/or some of its derivatives into routine practice as diagnostic tests will require in-depth understanding of the pitfalls of these technologies and a great degree of bioinformatic expertise. This article focuses on the contribution of next-generation sequencing technologies to diagnosis and cancer prognostication and prediction.

read more

Citations
More filters
Journal Article

Patterns of Somatic Mutation in Human Cancer Genomes

TL;DR: In this paper, the coding exons of the family of 518 protein kinases were sequenced in 210 cancers of diverse histological types to explore the nature of the information that will be derived from cancer genome sequencing.

SF-010-4 Distant metastasis occurs late during the genetic evolution of pancreatic cancer

TL;DR: A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell.
Journal ArticleDOI

The Genetic Basis for Cancer Treatment Decisions

TL;DR: The timing is right to develop a clinical trial and research framework to move future clinical decisions from heuristic to evidence-based decisions, and the challenges of integrating genomic testing into cancer treatment decision making are wide-ranging and complex.

How to map billions of short reads onto

TL;DR: In this paper, the authors map the vast quantities of short sequence fragments produced by next-generation sequencing platforms, and present a set of programs that can be used to map these fragments.
Journal ArticleDOI

Key Principles and Clinical Applications of “Next-Generation” DNA Sequencing

TL;DR: An overview of the capabilities and clinical applications of DNA sequencing technologies is provided to raise awareness among researchers about the power of these novel genomic tools and outline key advantages and disadvantages between different sequencing platforms to help researchers choose an appropriate platform for their research interests.
References
More filters
Journal ArticleDOI

DNA sequencing with chain-terminating inhibitors

TL;DR: A new method for determining nucleotide sequences in DNA is described, which makes use of the 2',3'-dideoxy and arabinon nucleoside analogues of the normal deoxynucleoside triphosphates, which act as specific chain-terminating inhibitors of DNA polymerase.
Journal ArticleDOI

Mapping and quantifying mammalian transcriptomes by RNA-Seq.

TL;DR: Although >90% of uniquely mapped reads fell within known exons, the remaining data suggest new and revised gene models, including changed or additional promoters, exons and 3′ untranscribed regions, as well as new candidate microRNA precursors.
Journal ArticleDOI

A method and server for predicting damaging missense mutations.

TL;DR: A new method and the corresponding software tool, PolyPhen-2, which is different from the early tool polyPhen1 in the set of predictive features, alignment pipeline, and the method of classification is presented and performance, as presented by its receiver operating characteristic curves, was consistently superior.
Journal ArticleDOI

RNA-Seq: a revolutionary tool for transcriptomics

TL;DR: The RNA-Seq approach to transcriptome profiling that uses deep-sequencing technologies provides a far more precise measurement of levels of transcripts and their isoforms than other methods.
Journal ArticleDOI

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

TL;DR: A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene which correlate with clinical responsiveness to the tyrosine kinase inhibitor gefitinib, and these mutations lead to increased growth factor signaling and confer susceptibility to the inhibitor.
Related Papers (5)